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Abstract
Macroautophagy is a cellular process whereby the cell sequesters and recycles cytosolic constituents in a lysosome-
dependent manner. It has also been implicated in a number of disorders, including cancer and neurodegeneration.
Although a previous report that AGS3 over-expression promotes macroautophagy suggests a stimulatory role of AGS3 in
this process, we have found that knock-down of AGS3, unexpectedly, also induces macroautophagy, indicating an inhibitory
function of endogenous AGS3 in macroautophagy. Interestingly, AGS3 phosphorylation is decreased upon induction of
mammalian target of rapamycin (mTOR)-dependent macroautophagy. Moreover, unlike wild-type AGS3, over-expression of
an AGS3 mutant lacking this modification fails to enhance macroautophagic activity. These observations imply that AGS3
phosphorylation may participate in the modulation of macroautophagy.
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Introduction
In eukaryotes, macroautophagy (hereafter simply referred to as
autophagy) is a universal metabolic process whereby the cell
encloses portions of its cytoplasm in a double membrane-bound
structure called an autophagic vacuole or autophagosome. The
autophagomes subsequently fuse with lysosomes, leading to the
degradation and recycling of the sequestered content [1]. While
autophagy was originally viewed as an inducible cellular
mechanism to provide an energy source during short-term
starvation, it has subsequently been shown that constitutive
autophagy mediates the elimination of protein aggregates or
damaged organelles and thus plays a protective role in multiple
cell types [2,3]. On the other hand, high levels of autophagy can
lead to cell death [4]. These observations suggest that autophagic
activity needs to be closely monitored and regulated within a cell.
Consistent with this notion, de-regulation of autophagic function
has been proposed to participate in neurodegenerative disease and
cancer [5], the innate immune response [6], as well as aging [7].
Although genetic screens have identified many proteins encoding
essential autophagic components, the characterization of the
mechanisms by which a cell regulates autophagic activity remains
incomplete. One major pathway that modulates autophagy
involves the mammalian Target of Rapamycin (mTOR), a Ser/
Thr kinase that functions as a signaling hub to control cell
proliferation, growth, and survival by regulating transcription,
translation, as well as autophagic activity [8]. Activation and
inhibition of mTOR, respectively, repress and enhance autoph-
agy, most likely by controlling the assembly of ATG1 complex
during the induction of autophagy [9,10,11]. Although mTOR
represents a major regulator of autophagy, several mTOR-
independent pathways of autophagy have been found [12,13].
Activator of G-protein Signaling 3 (AGS3; also known as
GPSM1) was first identified during a functional screen for
mammalian proteins that activate heterotrimeric G-protein
signaling in a receptor-independent manner in Saccharomyces
cerevisiae [14]. Sequence analysis of AGS3 reveals a 70 kDa protein
with a three-module structure, including seven tetratricopeptide
repeats (the TPR domains) at the N-terminus [15,16], a linker
domain in the middle, and four G-protein regulatory motifs (the
GPR or Goloco domains) at the C-termnius [17,18]. Biochemical
approaches have demonstrated that the GPR domains of AGS3
preferentially bind and stabilize GDP-bound Gai subunits
[19,20,21,22]. By acting as a guanine dissociation inhibitor
(GDI) of the Gai subunit, AGS3 may promote the dissociation
of Gabc or inhibit the re-association of Gai with the Gbc dimer.
As a consequence, AGS3 could potentially inhibit the Gai-
dependent pathways but enhance Gbc-regulated signaling.
Because of its abundant expression in neurons, most AGS3 studies
have focused on the brain. Studies in rodents have indicated that
the AGS3 level is up-regulated in specific brain regions, the
prefrontal cortex (PFC) and nucleus accumbens (NAC), during the
late withdrawal from drug or alcohol administration and that this
up-regulation plays a necessary and active role in various
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and the reinstatement of drug-seeking behavior [23,24,25]. AGS3
also functions in asymmetric cell fate by controlling mitotic
spindle orientation during brain development [26]. Despite the
importance of AGS3 for brain function, we and others have
shown that AGS3 is present in multiple tissues and cell types
[14,20,22,27,28,29,30] and displays a limited co-localization with
the markers of ER and Golgi [28]. Consistent with these
observations, our previous study revealed a potential role of
AGS3 in the structure and/or function of the Golgi apparatus
[30]. More recently, the study of AGS3 null mice has indicated an
unexpected function of AGS3 protein in metabolic and cardio-
vascular function [31], suggesting that a major function of AGS3 in
vivo lies in cell metabolism.
As a major AGS3-interacting protein [14,19,21,22,32], Gai3 has
been shown to control autophagic sequestration in colon carcinoma
cells [33]. Given the interaction between AGS3 and Gai3, Pattingre et
al. have over-expressed AGS3 and its truncation mutants in human
colon cancer HT-29 cells and examined their effects on autophagy
[28]. These authors show that AGS3 over-expression stimulates
autophagy, whereas over-expression of either the TPR or the GPR
domain suppresses it. However, whether and how endogenous AGS3
regulates autophagy is unknown. Moreover, considering that mTOR
is a major regulator of autophagy, it should be interesting to explore
the relationship between AGS3 and the mTOR pathway in the
context of autophagy. The answers to the above questions will
provide insight into the mechanism by which the intersection of
autophagy and G-protein signaling is regulated.
Materials and Methods
Cell Culture and Transfection
COS7 [30], HEK293 (ATCC CRL-1573) or HeLa [30] cells
were cultured in Advanced D-MEM medium (GIBCO) supple-
mented with 4% fetal bovine serum, 2 mM glutamine and 1X
penicillin-streptomycin (Cellgro). Cell starvation was performed by
incubating cells in HANKs or EBSS medium supplemented with
25 mM HEPES for 2 hrs. With the exception of the GFP-LC3
assays, cells were transfected with DNA (0.4 mg/ml) using
FuGENE6 HD (Roche) or siRNA (20 nM) using Lipofectamine
RNAiMAX (Invitrogen). Cell lysates were collected 24 hrs or
48 hrs after transfection, respectively, for DNA or RNA
transfections. The following siRNAs targeting human AGS3
(GPSM1) were purchased from QiagenAGS3 siRNA1: GGG
CGC UGG AAU ACC ACA A; AGS3 siRNA2: CCG AGU
UCU ACG AGA GGA A.
DNA Constructs and Site-Directed Mutagenesis
Rat AGS3 cDNA was obtained as previously described [30].
HA-AGS3, HA-AGS3TPR (residues 1–472) as well as the HA-
ASG3GPR (residues 461–650) constructs were PCR amplified
from the wild-type AGS3 construct and cloned into the pcDNA3
vector containing an N-terminal HA-epitope. The full length
AGS3 GPR ser/thr mutant was made using the Quikchange
Lightning Site-Directed Mutagenesis kit (Stratagene) and verified
by DNA sequencing. Serines (S) and threonines (T) present within
the last 183 amino acids of AGS3 were mutated to alanine, this
includes S467, S468, S478, S482, S483, T503, T507, S516, T518,
S520, T523, S532, S533, S535, S544, S547, T554, S583, S584,
T602, S610, S630, S636, and S650.
Cell Lysis
Cells were lysed in ice-cold RIPA lysis buffer (50 mM Tris HCl
[pH 80.], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
SDS and 1% sodium deoxycholate). Directly before addition of
the lysis buffer, Complete protease inhibitors (Roche) and 1 mM
PMSF were added. Following the clearing of lysates by
centrifugation for 10 min at 4uC, the lysates were adjusted to
the same volume and concentration of total protein as determined
by a Non-Interfering Total Protein assay (G Biosciences). Lysates
were incubated for 15 min at 90uC in SDS-PAGE loading buffer
supplemented with b-mercaptoethanol. Samples were stored at
220uC.
Antibodies
The following commercially available antibodies were used in
this study: rabbit polyclonal LC3B antibody (Cell Signaling),
rabbit polyclonal HA.11 antibody (Covance), mouse monoclonal
actin antibody (BD Biosciences), goat polyclonal DyLight 680 anti-
rabbit IgG (Jackson ImmunoResearch) and goat polyclonal
DyLight 680 anti-mouse IgG (Jackson ImmunoResearch). We
also raised a rabbit polyclonal antibody directed against a GST-
fusion of the C-terminal region (a.a. 461–650) of AGS3
(characterized below).
Immunoprecipitation
Cells were lysed as described above, with the exception that cells
were solublized in ice-cold NP-40 lysis buffer (50 mM Tris-HCl
[pH 8.0], 150 mM NaCl, 1 mM EDTA and 1% NP-40). After
protein quantification, lysates were incubated with the appropriate
primary antibody at 4uC for 2 hrs followed by incubation with
protein G-Sepharose (Invitrogen) for anther 2 hrs at 4uC. The
sepharose beads were washed four times in ice cold lysis buffer and
the bound proteins were eluted with SDS-PAGE sample buffer
supplemented with b-mercaptoethanol at 90uC for 15 min.
SDS-PAGE and Western Blot Analysis
Samples were separated by SDS-PAGE electrophoresis (6%–
13% gradient gels, BioRad), and transferred to Immobilon
0.45 mm PVDF membranes (Milipore) using a Semi-Dry Electro-
blotting System (Owl). Membranes were incubated with the
appropriate primary antibody overnight at 4uC in a 1:1 mixture of
Odyssey blocking buffer and PBS supplemented with 0.1%
Tween-20. Excess primary antibody was removed by performing
three 10 min washes with PBS supplemented with 0.1% Tween-
20. Secondary antibody incubation was performed in a 1:1
mixture of Odyssey Blocking buffer and PBS supplemented with
0.1% Tween-20 and 0.02% SDS for 30 min, following which the
membranes were washed with PBS supplemented with 0.1%
Tween-20 (three times for 5 min each) followed with PBS for
1 min and dried in the dark. Quantification was performed using
an Odyssey Infrared Imaging System.
GFP-LC3 Assay
One day before siRNA transfection, 8X10
6 HEK GFP-LC3
cells (a gift from Sharon Tooze; Cancer Research UK) were plated
in 60 mm dishes. Transfection with siRNA was performed using
10 ml Lipofectamine RNAiMAX transfection reagent (Invitrogen)
and 50 nM siRNA. 48 hrs after transfection the cells from each
plate were detached using Trypsin/EDTA and replated onto 4
fibronectin coated coverslips (for microscopy) as well as reseeded
onto a fresh 60 mm dish (for lysis and verification of knock-down
by western blot). The following day, cells growing on coverslips
were treated either with regular growth media (DMEM supple-
mented with 10% FBS), regular growth media containing 100 nM
bafilomycin A, starvation media (EBSS) or starvation media
(EBSS) with bafilomycin A1 for 2 hrs. Thereafter, cells were
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permeabilized for 5 min in ice-cold 0.05% saponin containing
PEM buffer (80 mM PIPES pH 6.8, 5 mM EGTA and 1 mM
MgCl2) prior to 15 min fixation in 4% paraformaldehyde.
Coverslips were mounted onto slides in Moviol supplemented
with 2 mg/ml Ho ¨echst and analyzed for GFP-LC3II puncta
formation on the high throughput Olympus ScanR microscope
using the fully automated acquisition and analysis platforms. For
each coverslip 64 images were acquired using the 40X objective
and the number of GFP-LC3II puncta was analyzed for each cell.
On average 1500–3000 cells were identified per coverslip.
Real-Time PCR
Total RNA from HEK293 cells treated with a non-targeting
control siRNA or AGS3 siRNA1 were isolated using an RNeasy
Plus Mini Kit (QIAGEN) and quantified with a nanodrop
spectrophotometer (Thermo Scientific). cDNA was synthesized
by reverse-transcription using the RevertAid First-Strand cDNA
synthesis kit (Fermentas) with a nonspecific oligo(dT) primer and
real-time PCR was performed in triplicate for each sample using
the iCycler iQ Real-Time PCR System (Bio-Rad). Approximately
100 bp of the cDNA of choice was amplified using two
independent sets of primers targeting distinct areas of the LC3
mRNA. The results from these primers were normalized using
those from four sets of primers targeting the cDNA sequences of
several ‘‘house-keeping’’ gene products (GAPDH, GPI (39), HMBS
and HPRT1).
Results
Both Knock-Down and Over-Expression of AGS3 Increase
LC3II Levels
Upon induction of autophagy, a cytosolic protein, microtubule-
associated protein 1 light chain 3 (LC3I) is processed and
covalently linked to a phosphatidylethanolamine moiety to yield
LC3II. This lipid-modified LC3II associates specifically with
autophagic membranes [34], and thus its levels can be used as to
measure of the amount of autophagic compartments [35]. To
assure ourselves that the change in LC3II levels can be used as an
indicator of altered autophagic activity in HEK293 cells, we
treated cells with rapamycin (100nM, 4 hrs) and measured both
the total LC3I and the LC3II levels by quantitative western blot
analysis. Rapamycin induces autophagy by forming a complex
with FKBP12 and directly inhibiting the mTOR activity
[36,37,38,39]. Indeed, the ratio of the levels of LC3II to LC3I
as well as those of LC3II alone were increased by approximately
40% and 35%, respectively, under our experimental conditions
(Figure 1A). Due to several caveats associated with LC3I detection
such as its sensitivity to degradation in SDS-sample buffer and to
freezing-thawing [35], the total LC3II level relative to actin has
been shown to be a more reliable indicator of autophagy than the
ratio of LC3II to LC3I. Thus, we measured the total LC3II level
and used actin as a loading control in the remainder of the study.
We next investigated the effects of over-expression and knock-
down of AGS3 on the levels of LC3II in HEK293 cells. Consistent
with a previous report by Pattingre, et al [28], the over-expression
of AGS3, but not an empty vector (pcDNA3) resulted in a 24%
increase in LC3II levels (Figure 1B). Interestingly, compared to a
non-targeting control siRNA, LC3II levels also rose in cells treated
with either of two siRNAs targeting different sites of AGS3 mRNA
(by 80% for siRNA1 and 48% for siRNA2; Figure 1C). Similar
results were obtained in HeLa cells (Figure 1D). Since both
siRNAs exert a similar effect, we used siRNA1 for subsequent
studies. To ask whether AGS3 also impacts induced autophagy,
we compared the effect of depleting AGS3 on the LC3II levels
under normal growth or starved conditions; the latter of which is
thought to trigger autophagy by indirectly inhibiting mTOR
activation via a less well understood signal transduction pathway
[40]. As shown in Figure 1E, suppression of AGS3 further
increased the LC3II level in starved cells.
Although an increased LC3II level, when measured by western
blot, is generally indicative of an increase in autophagosome
number, the relationship is not always linear [35]. As an
independent assay of autophagosome formation we utilized an
HEK293 cell line stably expressing a GFP fusion of LC3 [41,42]
and measured the influence of knocking-down AGS3 on the
formation of GFP positive structures under normal growth or
starved conditions. As with endogenous LC3I and LC3II proteins,
GFP-LC3I is not associated with a membrane and is thus found in
the cytoplasm, whereas GFP-LC3II exhibits a punctate pattern
due to its association with the autophagosome membrane. Since
the assay was performed after cell permeabilization (see ‘‘Materials
and Methods’’), the free GFP-LC3I is able to diffuse out, while the
membrane-bound GFP-LC3II is retained. Thus, the number of
GFP-positive puncta correlates with the number of autophagic
structures. Consistent with the results obtained above using
western blot analyses (Figure 1C-E), as well those from the
quantification of endogenous LC3II in the GFP-LC3 cell line
(Figure 1F), the fluorescent images show that AGS3-depleted cells
exhibit much more green puncta compared to the control cells
under both normal growth (data not shown) and starved
conditions, a conclusion which was further confirmed by the
quantification (Figure 1G). Relative to the control cells, a 3- and
2.2-fold increase of the number of GFP-LC3II puncta was
observed in AGS3 knock-down cells in normal growth and
starvation media, respectively. It should be noted that the ratio of
the non-starved AGS3 siRNA1 treated sample to the starved
control sample in the GFP-LC3II analysis is not the same as in the
western blot analyses; this could be due to the use of different cell
lines (HEK293 vs. HEK293 GFP-LC3 stable line), or as a result of
the differing natures of the two assays (the LC3II protein level vs.
the number of GFP-LC3II puncta structures). Taken together, the
above data suggest that loss of AGS3 leads to an increased number
of autophagosomes within the cell under both normal growth and
starved conditions.
AGS3 Knock-Down Increases Autophagic Activation
The number of autophagosomes found within a cell depends on
both the induction of autophagy, as well the rate of their
degradation, which occurs upon fusion with the lysosome. AGS3
knock-down could conceivably increase the number of autophago-
somes and thus the level of LC3II by either inducing autophago-
some formation or by preventing their turnover. It is important to
distinguish between these two scenarios since they indicate
opposite effects of AGS3 in autophagy (stimulation in the former
and inhibition in the latter). To address this question, we made use
of the same two approaches described above to investigate the
impact of AGS3 depletion on the bafilomycin A1-induced increase
in autophagosome number. As a vacuolar-type H
+-ATPase
inhibitor, bafilomycin A1 blocks the fusion between autophago-
somes and lysosomes and thus the degradation of LC3II [43,44]. If
AGS3 knock-down inhibited the fusion between autophagosomes
and lysosomes, we would expect that the level of LC3II or the
number of GFP-LC3II puncta in AGS3 knock-down cells would
not increase any further in the presence of bafilomycin A1.
However, as shown in Figure 2, the increase of both the level of
LC3II (Figure 2A) as well as the number of GFP-LC3II puncta
(Figure 2B) persisted in AGS3 knock-down cells treated with
AGS3, mTOR-Dependent Autophagy
PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8877Figure 1. Both knock-down and over-expression of AGS3 lead to an increased LC3II level in HEK293 and HeLa cells. Cells transfected
with DNA (0.4 mg/ml) or siRNA (20 nM) were lysed 24 or 48 hrs after transfection, repectively, unless otherwise noted. b-actin was used as a loading
control. (A)Theeffect of rapamycin (100 nM, 4 hrs) on the level of LC3II in HEK293cells. (B)Theimpact of AGS3 over-expressionon LC3II in HEK293 cells.
Cells transfected with an empty vector (pcDNA3) were used as a negative control. (C) The influence of AGS3 knock-down on LC3II in HEK293 cells. Cells
transfected with a non-targeting siRNA were used as a negative control. (D) The influence of AGS3 knock-down on LC3II in HeLa cells. Western blot LC3II
band intensities are normalized to that of the control siRNA treated cells (arbitrarily set as 1X). (E) HEK293 cells were treated with either a non-targeting
control siRNA or AGS3 siRNA1andeitherstarved (2 hrs) or not. (F)GFP-LC3 stable HEK293 cells were treated with eithera non-targetingcontrol siRNA or
AGS3 siRNA1 and endogenous LC3 was assayed by western blot. Western blot band intensities are normalized to that of the control siRNA treated cells
(arbitrarily set as 1X). (G) HEK293 cells stably expressing GFP-LC3 were treated with AGS3 siRNA1 (50 nM, 72 hrs) and either starved (2 hrs) or not; a
higher AGS3 knock-down efficiency was obtainedfor the HEK293 GFP-LC3 stable cells when using a highersiRNAconcentration anda longerincubation
time. This could be due to differences in cell origin. The number of GFP positive puncta structures were quantified as described in the ‘‘Materials and
Methods’’. For the sake of clarity normalized GFP-LC3II counts/cell (n=6, approximately 10,000 cells/condition) are shown. Two statistical tests (ANOVA
and single-sample Student’s t-test) performed on LOG transformed data revealed that the AGS3 effect was significant across all experimental conditions
(p,0.05forStarved,p,0.01forallothers).Theimagesontheleftsidearerepresentativefullsizeacquiredimages,theinsettotherightshowsaclose-up
ofonecellwithindicationofdetectedGPFpuncta(redcircles).Thegreendottedlinesenclosethecellnuclei.Representativeblotsandimagesareshown
(AGS3 was detected using a rabbit polyclonal antibody characterized below). Data presented in bar graphs is the average result from at least three
independent experiments except in (G). Error bars: standard error of the mean. Asterisks - *=p,0.05, **=p,0.01, paired Student’s t-test.
doi:10.1371/journal.pone.0008877.g001
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function to inhibit the fusion between autophagosomes and
lysosomes. A similar observation was made when we used two
inhibitors of lysosomal enzymes, pepstatin A and E64d (data not
shown). When combined with the data from Figure 1, these results
indicate that AGS3 knock-down increases autophagosome number
by promoting their formation rather than by inhibiting their
degradation.
Further support for the above model comes from comparing the
effects of AGS3 depletion on the mRNA and protein levels of
LC3. Although a real-time PCR analysis revealed an ,2.5 fold
increase in the level of LC3 mRNA in AGS3 knock-down cells
compared to the control (Figure 2C), indicating elevated synthesis
of LC3 protein, there was no corresponding increase of the level of
LC3I protein (Figure 2D). These observations suggest that the
amount of LC3I converted to LC3II is increased in cells treated
with AGS3 siRNA.
AGS3 Phosphorylation Within Its GPR Domain Is Sensitive
to the Induction of mTOR-Dependent Macroautophagy
To further characterize the role of endogenous AGS3 in
autophagy, we raised a polyclonal rabbit antibody against the
GPR domain of AGS3. Interestingly, our antibody recognized
three differentially migrating species in HeLa cells (Figures 1D &
3), as well as in HEK293 (Figures 1 & 2) and COS7 (see below).
We chose to investigate these bands in HeLa because compared to
HEK293 and COS7, HeLa cells tend to express exogenously
introduced protein at a lower level, thus facilitating the separation
and analysis of the triplet on SDS-PAGE.
To determine whether the triplet visualized by western blot was
indeed AGS3, we knocked-down endogenous AGS3 in HeLa cells
with either of two siRNAs targeting AGS3 (Figure 3B). Indeed, all
three bands were significantly reduced following siRNA transfec-
tion, indicating that they are derived from AGS3. Moreover,
exogenous expression of an HA-tagged AGS3 resulted in a similar
triplet on SDS-PAGE (Figure 3C), suggesting that these bands are
generated via covalent modification(s) and/or protein degradation.
Finally, the comparison between the mobility of endogenous
AGS3 and that of a recombinant AGS3 (Figure 3D) further shows
that the slowest-migrating band of the triplet is most likely
covalently modified.
Early studies have shown that AGS3 can exist in a
phosphorylated state ([45,46]; Phosphosite.org). To test if the
slowest-migrating band represents a phosphorylated form of
AGS3, we immunoprecipitated endogenous AGS3 using our
AGS3 antibody, incubated the immunoprecipitated AGS3 in the
presence of Antarctic phosphatase (Figure 4A) or Calf Intestine
Phosphatase (data not shown), and analyzed AGS3 migration on
SDS-PAGE by western blotting. As evident from Figure 4A, the
slowest-migrating species of AGS3 is susceptible to the phospha-
tase treatment, implying that it is a phosphorylated species. The
same result was obtained using an HA-tagged AGS3 immuno-
precipitated with a rabbit polyclonal antibody against the HA-
epitope (data not shown). As it has been reported that the GPR
or GoLoco domain of AGS3 can be phosphorylated [45], we
next determined whether the phosphorylation that we observed
also occurs in the same domain. For this, we made use of two
Figure 2. The effect of AGS3 depletion on LC3II persists when
the fusion between autophagosomes and lysosomes is inhib-
ited in HEK293. siRNA-mediated knock-down of AGS3 was performed
as described in Figure 1. (A) The impact of AGS3 knock-down on the
LC3II level in the presence of bafilomycin A1. Cells transfected with a
non-targeting control siRNA or AGS3 siRNA1, were treated with either
DMSO alone (as a negative control) or bafilomycin A1 (100 nM, 2 hrs).
(B) The influence of AGS3 suppression on the number of GFP-LC3II
puncta in HEK293 stable cells treated with bafilomycin A1 (100 nM,
2 hrs). Cells stably expressing GFP-LC3 were first transfected with a non-
targeting control siRNA or AGS3 siRNA1 and the GFP-LC3II puncta was
quantified and the statistical analysis performed as described in Figure 1;
in both conditions the difference between control siRNA and AGS3
siRNA1 samples is statistically significant (p,0.01). Normalized GFP-
LC3II counts/cell (n=4, approximately 10,000 cells/condition) are
shown. (C) The effect of AGS3 depletion on the mRNA level of LC3.
HEK293 cells were treated with a non-targeting control siRNA or AGS3
siRNA1; total RNA was collected, reverse-transcribed and analyzed by
real-time PCR. Results were normalized to four ‘‘house-keeping’’ gene
products. (D) The LC3I levels in HEK293 cells treated with either a non-
targeting control siRNA or AGS3 siRNA1 determined by western blot.
Data presented in all bar graphs is the average result from three (A, C &
D) or four (B) independent experiments. The values of untreated control
and knock-down cells presented in (B) are provided for the sake of
comparison and are the same as those that appear in Figure 1G. Error
bars: standard error of the mean. Asterisks - *=p,0.05, **=p,0.01,
paired Student’s t-test. Representative blots are shown. Similar results
as those presented in 2A were obtained in HeLa cells (data not shown).
doi:10.1371/journal.pone.0008877.g002
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GPR domain (residues 461–650; HA-AGS3GPR) and the other
consisted of an HA epitope fused to the TPR domain and part of
the linker region (residues 1–472; HA-AGS3TPR). Although
HA-AGS3TPR migrates as one band (Figure 4B), HA-
AGS3GPR migrates as two species (Figure 4C). Moreover, the
level of the slower migrating species of HA-AGS3GPR was
greatly reduced after the phosphatase treatment (Figure 4C).
Collectively, our data show that the slowest-migrating band
represents a species of AGS3 which is phosphorylated in its GPR
domain.
Since our above studyimplies a role of AGS3 in the formation
of autophagosomes, we examined whether the level or
phosphorylation of AGS3 is altered upon autophagic induction.
Although rapamycin (100 nM, 4 hrs) or starvation (Hanks’
medium, 2 hrs) treatment did not significantly change the total
AGS3 protein levels, both treatments caused a great decrease in
the level of the slowest-migrating form of AGS3 (Figure 4D). We
also assessed whether the level of the slowest-migrating band
was also sensitive to the addition of LiCl (10 mM, 24 hrs) to the
culture medium. In contrast to rapamycin and amino acid
starvation, LiCl activates autophagy independent of mTOR
Figure 3. A rabbit polyclonal antibody detects an AGS3 post-translational modification in HEK293 and HeLa cells. DNA and siRNA
transfections were performed as described in Figure 1. (A) In HeLa cells, exogenously over-expressed untagged-AGS3 as well as endogenous AGS3
exhibited three differently migrating bands (indicated by asterisks). (B) Characterization of the putative AGS3 bands using lysates collected from HeLa
cells transfected with AGS3 siRNAs. The presence of three differently migrating bands which are sensitive to the AGS3 siRNAs is also evident in
HEK293 cells (Figures 1C, 1E & 2A). (C) Analysis of the band pattern of an HA-tagged AGS3 expressed in HeLa cells. (D) Comparison of the mobility
between recombinant AGS3 expressed in E. coli and endogenous AGS3 from HeLa cell lysate.
doi:10.1371/journal.pone.0008877.g003
Figure 4. Characterization of the slowest-migrating species of AGS3 and its sensitivity to mTOR-dependent autophagy. DNA
transfections were performed as described in Figure 1. (A) Western blot analysis of AGS3 immunoprecipitated from HeLa cell lysates in the presence
or absence of Antarctic phophatase. (B) Western blot analysis of a truncated AGS3 construct (HA-AGS3TPR; a.a. 1–472) consisting of the N-terminal
TPR domains immunoprecipitated from HeLa lysates. The lower light band likely represents a non-specific signal as it appears in both lanes. (C)
Western blot analysis of the phosphatase treatment of a truncated AGS3 construct (HA-AGS3GPR; a.a. 461–650) consisting of the C-terminal GPR
domains immunoprecipitated from HeLa lysates. (D) The influence of mTOR-dependent and –independent autophagic inductions on the triplet of
AGS3. Autophagy was induced in HeLa cells by inhibiting mTOR activity, via either rapamycin (100nM, 4 hrs) or starvation (2 hrs), or by an mTOR-
independent pathway via LiCl (10 mM, 24 hrs).
doi:10.1371/journal.pone.0008877.g004
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increased the level of LC3II, it failed to impact the level of
the slowest-migrating AGS3 band. Taken together, our data
indicate that a pool of AGS3 is phosphorylated in the GPR
domain and that this modification is sensitive to the induction of
mTOR-dependent autophagy. Since the knock-down of AGS3
does not have a detectable impact on the phosphorylation of S6
kinase 1, an established target of mTOR ([48,49]; data not
shown), AGS3 likely functions to modulate autophagy down-
stream of mTOR.
The AGS3 GPR Phospho-Mutant Fails to Induce
Autophagy When Over-Expressed
The above finding prompted us to explore whether the GPR-
phosphorylated species of AGS3 plays a part in the AGS3
autophagy phenotype. To address this question, using the full-
length wild-type AGS3 as a template, we systematically
mutated all 22 of the serine and threonine residues within the
GPR domain (a.a. 469–650), as well as 2 serines lying just
outside, into alanines (tyrosine is not present within the GPR
domain) by site-directed mutagenesis. As expected, this AGS3
mutant does not display the band corresponding to the slowest-
migrating species of AGS3 (Figure 5A). The following two
observations imply that the loss of phosphorylation of this
mutant is not due to a global folding defect. First, the AGS3
GPR phospho-mutant was expressed at a comparable level with
that of wild-type AGS3 (Figure 5A). Second, the mutant
retained the ability to co-immunoprecipitate Gai2/Gai3
(Figure 5B). Importantly, unlike wild-type AGS3, over-expres-
sion of the AGS3 phospho-mutant had no influence on the
LC3II level in HEK293 cells (Figure 5C). Similar results were
found in COS7 and HeLa cell lines (Figure 5D). These
observations raise the possibility that the phosphorylation of
AGS3 within its GPR domain may play a role in regulating
mTOR-dependent autophagy.
Discussion
While a previous study has shown that AGS3 over-expression
increases autophagic activity in human intestinal HT-29 cells,
suggesting a stimulatory role of this protein in autophagy [28], it
has remained unknown whether or how endogenous AGS3
functions in autophagy. Here, we provide evidence that, similar
to AGS3 over-expression, AGS3 knock-down also enhances
autophagic activity in HEK293 and HeLa cells. This conclusion,
albeit somewhat unexpected, is based on the following two sets of
observations. First, AGS3 knockdown leads to an increased
steady-state accumulation of LC3II protein level (as measured by
western blot), as well as an increased number of autophagic
structures (as measured by GFP-LC3II puncta) (Figure 1).
Second, when the lysosomal degradation of LC3II is blocked
by bafilomycin A1 in AGS3 knock-down cells, a further increase
in the level of LC3II protein or in the number of GFP puncta is
observed, indicating that AGS3 depletion likely enhances the
formation of autophagosomes (Figure 2). It is intriguing to note
that the AGS3 knock-out mice exhibit a lean phenotype [31], in
l i g h to fr e c e n tr e s e a r c hs u g g e s t i n gt h a ta u t o p h a g yr e g u l a t e sl i p i d
metabolism [50].
Our finding that both over-expression and knock-down of
AGS3 cause increased autophagic activity seems peculiar but is
consistent with other scenarios where over-expression of a wild-
type protein results in a dominant negative effect [51,52]. One
explanation for our observation is that AGS3 normally functions
in the context of a complex composed of multiple components in a
specific stoichiometry. Under these conditions, either an elevated
(in the case of over-expression) or decreased (in the case of knock-
down) level of AGS3 could inhibit the formation of this functional
complex, and thus cause a similar phenotype. As further support
for this model, we previously reported that both over-expression
and knock-down of AGS3 results in a similar dispersal of several
trans-Golgi network (TGN) proteins [30]. In this scenario, one
may also imagine that a more moderate increase (instead of the
relatively high level that occurs when AGS3 is over-expressed) of
AGS3 level could actually inhibit autophagy. Identification of
additional AGS3-interacting proteins should provide clues on this
topic.
The observations that the phosphorylation level of AGS3 is
inversely correlated with the autophagic activity (Figures 4), and
that the over-expression of a GPR phospho-mutant of AGS3 fails
to induce autophagy as wild-type AGS3 does (Figure 5) raise the
intriguing possibility that a phosphorylation switch controls the
function of AGS3 in autophagy. The fact that the level of
the slowest-migrating phosphorylated band of AGS3 is greatly
decreased when autophagy is induced by rapamycin or starvation,
but not by LiCl, implies that ASG3 is acting along the mTOR-
dependent autophagic pathway. How does AGS3 inhibit autoph-
agy? Based on our data, one attractive hypothesis is that mTOR or
one of its downstream effectors phosphorylates AGS3 and the
phosphorylated AGS3 contributes to the mTOR-mediated
suppression of autophagy. When mTOR activity is inhibited by
either rapamycin or starvation, AGS3 becomes de-phosphorylated
and the autophagic activity is increased accordingly. In a similar
fashion, ULK1-Atg13-FIP200 regulation of autophagic activity is
mediated by mTOR association and phosphorylation [10,11].
Previously, an AGS3 phosphorylation site at Ser 630 was identified
in a phosphoproteomic analysis [46]. Unfortunately, AGS3
constructs that we characterized carrying mutations of the site to
Ala or Asp did not affect the level or mobility of slowest-migrating
band, implying that another phosphorylation site or sites are
involved in our observations reported here (data not shown).
Moreover, although LKB1 has been reported to phosphorylate the
GPR domain of AGS3 [45], LKB1 depletion did not exert a
detectable impact on the slowest-migrating band under our
experimental conditions (unpublished observation). Identification
of the kinase and phosphatase controlling the formation and
removal of the slowest-migrating AGS3 phosphorylation band, as
well as the corresponding site(s) of phosphorylation, would
certainly provide further insight. An alternative possibility is that
AGS3 may inhibit autophagy independent of its phosphorylation
status and the disappearance of the slowest-migrating phosphor-
ylated band of AGS3 is merely a consequence of autophagic
degradation. Under this condition, the inability of the phospho-
mutant of AGS3 to induce autophagy can be due to the loss of a
yet-to-be identified autophagy factor, which normally modulates
autophagy by binding to the AGS3 GPR domain irrespective to
the phosphorylation status of AGS3, but can no longer recognize
the mutated AGS3 form. In this aspect, identification of additional
AGS3-interacting proteins may prove helpful. Finally, we would
also like to point out that, while the GPR phospho-mutant of
AGS3 co-immunoprecipitates Gai2/Gai3 to a level comparable to
wild-type AGS3, our data do not rule out a role of Gai3 in
autophagy.
Another related question is the precise role of AGS3 in
autophagy. Both the previous [28] and our current studies have
indicated that AGS3 functions during an early stage of autophagy,
instead of the fusion step between autophagosomes and lysosomes.
One possible, albeit less likely, mode of AGS3 action is through the
transcriptional control of autophagy regulating genes, as revealed
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mRNA level of LC3 (Figure 2C). Another mechanism by which
AGS3 may affect the induction of autophagy is by modulating
autophagosome formation in the cytosol. In this regard, the
elevated LC3 mRNA observed in cells depleted of AGS3 may be a
consequence of AGS3-mediated induction of autophagy. It is
noteworthy that increasing evidence has suggested a potential link
between the ER/Golgi compartments and the autophagic
machinery [53,54]. Moreover, as a major AGS3 interacting
partner, Gai3 is enriched at the Golgi apparatus in many cell types
[55,56,57,58,59,60]. Considering that a pool of AGS3 resides at
the ER/Golgi compartments [28] and that knock-down of AGS3
leads to an altered distribution of several TGN proteins [30], one
intriguing question to be addressed is whether AGS3 affects
autophagosome formation via its effect on these vesicular
compartments.
Figure 5. Over-expression of the AGS3 phospho-mutant does not induce autophagy in HEK293 HeLa or COS7 cells. DNA
transfections were performed as described in Figure 1. (A) Western blot analysis of the AGS3 GPR phospho-mutant (all Ser and Thr within last
the C-terminal 183 a.a. mutated to Ala) expressed in HEK293 cells. (B) Co-immunoprecipitation of Gai2/Gai3 with either wild-type AGS3 or the
AGS3 phospho-mutant from HEK293. (C) Assessment of the ability of AGS3 GPR phospho-mutant to induce autophagy in HEK293 cells. HEK293
cells transfected with the vector alone, AGS3 or AGS3 GPR phosphor-mutant were lysed and LC3II levels was assayed. (D) Assessment of the
ability of AGS3 GPR phospho-mutant to induce autophagy in COS7 and HeLa cells. Representative blots are shown. Data presented in the bar
graph in (B) are the average results from at least three independent experiments. Error bars: standard error of the mean. Asterisks=p,0.01,
paired Student’s t-test. Western blot band intensities in (D) are shown as normalized to that of vector (i.e. pcDNA3) transfected cells (arbitrarily
set as 1X).
doi:10.1371/journal.pone.0008877.g005
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